Initiatives to Tackle Anaemia in Pregnant Women
Health is a state subject and the primary responsibility for strengthening health care services including implementation of national programs lies with the respective State/UT government. However, Government has taken steps to improve the condition of anaemia among all identified groups in all States/UTs.Under National Health Mission (NHM) the Government provides financial and technical support to […]
PLI scheme for Bulk Drugs
In total 239 applications have been received for the 36 products spread across the 4 Target Segments for the PLI schemes for Bulk Drugs from all over the country in two rounds of applications. Out of these, 49 applications have been approved by the Government till date. The Government promoted the Scheme by holding meetings […]
Detection, Management and Treatment of Cases of Depression
As per the National Mental Health Survey 2016, conducted by National Institute of Mental Health and Neuro Sciences, Bengaluru in 12 States of the country, the prevalence of depressive disorders among adults (18+ years) in India is estimated to be 2.7%. As per the survey, mental health problems are both a cause and consequence of […]
Mental Health Issues In The Country
Under District Mental Health Programme, fund of Rs. 84.13 Crore have been approved for States/UTs under National Health Mission for the year 2020-21. Under the Tertiary care component of National Mental Health Programme, 25 Centers of Excellence and 47 PG Departments have been sanctioned to increase the intake of students in PG departments in mental […]
Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting
First data showing OCREVUS treatment effect on disability progression in non-active secondary progressive multiple sclerosis and further data in primary progressive MS will be presented Evrysdi data continue to demonstrate long-term efficacy and safety in a broad population of people with spinal muscular atrophy Longer-term efficacy and safety for Enspryng in neuromyelitis optica spectrum disorder […]
CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma
Polivy plus R-CHP showed first clinically meaningful improvement in PFS with comparable safety in people with previously untreated diffuse large B-cell lymphoma (DLBCL) over the standard of care in more than 20 years Approximately 40% of people with previously untreated DLBCL are not cured with the current standard of care and face a poor prognosis […]
WHO establishes the Global Centre for Traditional Medicine in India
Maximizing potential of traditional medicines through modern science and technology Geneva--25 March 2022--The World Health Organization (WHO) and the Government of India today signed an agreement to establish the WHO Global Centre for Traditional Medicine. This global knowledge centre for traditional medicine, supported by an investment of USD 250 million from the Government of India, […]
Government Steps to Curb Type-1 Diabetes
For maintaining Diabetes record, there is a registry maintained by the Indian Council of Medical Research called as the Young Diabetes Registry (YDR) since year 2006. The YDR registry recruits patients with young onset diabetes, diagnosed on or before 25 years of age. The registry operates at 205 centres from 10 cities across India. According […]
Enhancement Of Healthcare Workforce
Regarding healthcare/medical professionals in the country, there are 13,01,319 allopathic doctors registered with the State Medical Councils and the National Medical Commission (NMC) as on November, 2021. The doctor-population ratio is 1:834 in the country assuming 80% availability of registered allopathic doctors and 5.65 lakh AYUSH doctors. Also, there are 2.89 lakh registered dentists, 32.63 […]
Pricing Policy of Medicines
The extant National Pharmaceutical Pricing Policy (NPPP), notified on 7th December, 2012, has been formulated with an objective to put in place a regulatory framework for pricing of drugs so as to ensure availability of essential medicines at reasonable prices while providing sufficient opportunity for innovation and competition to support the growth of pharma industry. […]
